A new study indicates that the brain-boosting benefits of psychological resilience — including overcoming conditions like persistent loneliness — might offset harm and ultimately…
Amylyx Pharmaceuticals’ neurodegeneration drug, AMX0035, has been studied in volunteers with mild cognitive impairment (MCI) or Alzheimer’s in a Phase 2 clinical trial. Topline…
As part of our LiveTalk series, Being Patient spoke with speech-language pathologist Vicky Fukuhara about strategies to help people with dementia cope with declining…
What if we think of Alzheimer’s not as one disease, but three separate ones, with overlapping symptoms? Researchers behind a new study say Alzheimer’s…
Being Patient will speak with Brian LeBlanc about his journey of finding meaning and new relationships after he was diagnosed with early-onset Alzheimer’s in…
Being Patient will speak with talk show host Leeza Gibbons about her late mother’s almost decade-long battle with Alzheimer’s, and her mission to support…
This weekend, new batch of data from the TRAILBLAZER-ALZ trial for Eli Lilly’s Alzheimer’s drug donanemab was released, upholding the treatment’s ability to affect…